Sandra D. van der Vaart - 13 Aug 2025 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Reporting relationship: EVP, Chief Legal Officer
Issuer ticker: LH
Reported as of: 13 Aug 2025
Net transaction value: -$546,400
SEC form: 4
Accepted by SEC: 15 Aug 2025, 10:55:59 UTC
Prior SEC filing: 05 May 2025
Next SEC filing: 10 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Sandra D. van der Vaart

Key filing fact

Sandra D. van der Vaart filed Form 4 for LABCORP HOLDINGS INC. (LH) on 15 Aug 2025.

Key facts

This page summarizes Sandra D. van der Vaart's Form 4 filing for LABCORP HOLDINGS INC. (LH).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Aug 2025, 10:55.

Change

Previous filing in this sequence was filed on 05 May 2025.
Current net transaction value: -$546,400.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001537208 Primary reporting owner

van der Vaart Sandra D

Relationship: EVP, Chief Legal Officer
Address: 531 SOUTH SPRING STREET, BURLINGTON
Signature: /s/ Sandra D. van der Vaart
Signature date: 15 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LH transaction

Common Stock

Options Exercise

Transaction value: $512,971
Shares: +3,903
Change %: +172%
Price: $131.43
Shares after: 6,177
Date: 13 Aug 2025
Ownership: Direct
Footnotes: F1

LH transaction

Common Stock

Sale

Transaction value: $1,059,371
Shares: -3,903
Change %: -63%
Price: $271.42
Shares after: 2,274
Date: 13 Aug 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LH transaction Derivative

Non-qualified Stock Options

Options Exercise

Transaction value: $0
Shares: -3,903
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 13 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,903
Exercise price: $131.43
Footnotes: F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Amount includes 30.1294 shares acquired on June 30, 2025 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan.

Footnote F2

Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.

Footnote F3

Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.

Footnote F4

The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.